Erratum to: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells

Ítems similars

• Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells
  per: Jing, Hongyu, et al.
  Publicat: (2016)
• Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
  per: He, Qing, et al.
  Publicat: (2016)
• Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
  per: He, Qing, et al.
  Publicat: (2017)
• Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro
  per: Yamaguchi, Masayoshi, et al.
  Publicat: (2018)
• Erratum to “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells”
  per: Jung, Ji Hoon, et al.
  Publicat: (2019)